Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience.
about
Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Efficacy, toxicity and cost an ...... single-institution experience.
@en
Efficacy, toxicity and cost an ...... single-institution experience.
@nl
type
label
Efficacy, toxicity and cost an ...... single-institution experience.
@en
Efficacy, toxicity and cost an ...... single-institution experience.
@nl
prefLabel
Efficacy, toxicity and cost an ...... single-institution experience.
@en
Efficacy, toxicity and cost an ...... single-institution experience.
@nl
P2093
P2860
P1476
Efficacy, toxicity and cost an ...... single-institution experience.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2354.2007.00816.X
P407
P577
2008-03-01T00:00:00Z